This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try an an out-of-the-box approach. These stocks include American Eagle Outfitters (AEO), Groupon (GRPN), Nextracker Inc. (NXT), ESS Tech (GWH) and Virgin Galactic (SPCE).
Virgin Galactic (SPCE) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Virgin Galactic (SPCE) delivered earnings and revenue surprises of 35.12% and 13.55%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
L3Harris (LHX) Q3 Earnings Top Estimates
by Zacks Equity Research
L3Harris (LHX) delivered earnings and revenue surprises of 2.14% and 0.45%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Boeing (BA) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Boeing (BA) delivered earnings and revenue surprises of -0.97% and 0.02%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Lockheed Martin (LMT) Q3 Earnings Top Estimates
by Zacks Equity Research
Lockheed (LMT) delivered earnings and revenue surprises of 5.72% and 1.05%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Northrop to Report Q3 Earnings: Will Lower Share Count Benefit?
by Zacks Equity Research
NOC has an Earnings ESP of +1.12% and a Zacks Rank #2 at present. These increase the chances of an earnings beat this reporting cycle.
How to Boost Your Portfolio with Top Aerospace Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
by Zacks Equity Research
Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic have been highlighted in this Screen of The Week article.
Lockheed (LMT) Soars 3.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Lockheed (LMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Adverum Biotechnologies (ADVM), IceCure Medical (ICCM), DarioHealth (DRIO), Energous (WATT) and Virgin Galactic (SPCE).
How to Find Strong Aerospace Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
3 Space Stocks Set to Rocket
by Andrew Rocco
The future is now, and the space frontier is for the taking. Though space stocks are inherently risky, LUNR, ASTS, and RKLB have the potential to rocket higher.
Does Virgin Galactic (SPCE) Have the Potential to Rally 467.09% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Virgin Galactic (SPCE) points to a 467.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
3 Aerospace-Defense Stocks to Buy Amid Solid US Defense Budget
by Aparajita Dutta
Aerospace-Defense stocks ride high on impressive air passenger view and solid US defense budget amid the adverse impacts of supply-chain challenges. You may buy LDOS, SPCE and AIRI.
Wall Street Analysts Predict a 420.73% Upside in Virgin Galactic (SPCE): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 420.7% upside potential for Virgin Galactic (SPCE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Virgin Galactic (SPCE) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Virgin Galactic (SPCE) delivered earnings and revenue surprises of 19.26% and 20.57%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Virgin Galactic (SPCE) in Q2 Earnings?
by Zacks Equity Research
Virgin Galactic's (SPCE) Q2 results are likely to reflect the benefits of commercial spaceflights as well as lower materials and consulting expenses amid the adverse impacts of higher interest expenses.
Virgin Galactic (SPCE) Surges 7.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Virgin Galactic (SPCE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Redwire Corporation (RDW) Soars 9.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Redwire Corporation (RDW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Virgin Galactic (SPCE) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Virgin Galactic (SPCE) delivered earnings and revenue surprises of 3.85% and 0.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Virgin Galactic (SPCE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Virgin Galactic (SPCE) settling at $0.88, representing a -0.41% change from its previous close.
Virgin Galactic (SPCE) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
The latest trading day saw Virgin Galactic (SPCE) settling at $0.86, representing a -1.09% change from its previous close.
Northrop Grumman (NOC) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Northrop Grumman (NOC) delivered earnings and revenue surprises of 8.40% and 3.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Virgin Galactic (SPCE) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Virgin Galactic (SPCE) closed the most recent trading day at $1.04, moving +1.96% from the previous trading session.
Virgin Galactic (SPCE) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Virgin Galactic (SPCE) reachead $1.24 at the closing of the latest trading day, reflecting a -1.59% change compared to its last close.